Skip to main content
Transpek Industry Ltd. logo

Transpek Industry Ltd. — Investor Relations & Filings

Ticker · TRANSPEK ISIN · INE687A01016 LEI · 335800RB49U7JFY3VP05 BSE.NS Manufacturing
Filings indexed 471 across all filing types
Latest filing 2025-06-25 Board/Management Inform…
Country IN India
Listing BSE.NS TRANSPEK

About Transpek Industry Ltd.

https://transpek.com/

Transpek Industry Ltd. is a manufacturer specializing in the synthesis of acid chlorides and sulfur-based chemicals. The company focuses on the production of Thionyl Chloride and its derivatives, serving as a critical supplier for the pharmaceutical, agrochemical, and performance polymer sectors. Its core competencies include complex chemical processes such as chlorination, which facilitates the creation of high-purity intermediates. Transpek maintains a strong emphasis on research and development to optimize process chemistry and scale up specialized molecules. The company provides a diverse portfolio of products, including Isophthaloyl Chloride (IPC) and Terephthaloyl Chloride (TPC), utilized in the manufacturing of high-strength fibers and engineering plastics. With a focus on safety and environmental compliance, it manages large-scale hazardous chemical operations to support global supply chains.

Recent filings

Filing Released Lang Actions
Intimation of Resignation of Shri Ramkisan Devidayal, Independent Director of the Company.
Board/Management Information Classification · 100% confidence The document is a resignation letter from a director of the company addressed to the Board of Directors. It details the resignation from the office of Director and Chairman of certain committees due to health reasons. There is no financial data, no report, no regulatory filing beyond the resignation notice, and no mention of any other type of report or announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-06-25 English
Investor Presentation for the May, 2025
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' for Transpek Industry Limited dated May 2025. It contains detailed financial highlights for Q4 and FY25, including revenue, EBITDA, PAT, segment and regional sales breakdowns, consolidated profit & loss account, balance sheet, and cash flow statement. It also includes business highlights, strategic outlook, awards, and FAQs. The content is typical of an investor presentation focusing on financial performance, business strategy, and market positioning rather than a formal annual report or regulatory filing. The length is substantial (15,000 characters), and it is not merely an announcement or certification. Therefore, the document fits the category of an Investor Presentation (IP).
2025-05-16 English
Annual Secretarial Compliance Report for the year ended 31.03.2025
Regulatory Filings
2025-05-13 English
Intimation of appointment of Secretarial Auditor
Regulatory Filings
2025-05-07 English
Results for the quarter and year ended 31.03.2025
Regulatory Filings
2025-05-07 English
Transpek Industry Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 ,inter alia, to consider and approve The Audited Standalone and ....
Regulatory Filings Classification · 95% confidence The document text is extremely short (90 characters) and contains only a digital signature with a date and name, without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. This matches the criteria for a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2025-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.